Leffers, Ninke <br/><br/>
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.  [electronic resource] 

 -  International journal of cancer  Nov 2009 
 - 2104-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.24597  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amino Acid Sequence<br/>Cancer Vaccines--adverse effects<br/>Cell Movement<br/>Female<br/>Humans<br/>Immunization<br/>Interferon-gamma--biosynthesis<br/>Lymphocyte Activation<br/>Middle Aged<br/>Molecular Sequence Data<br/>Ovarian Neoplasms--immunology<br/>Peptide Fragments--immunology<br/>Pregnancy<br/>T-Lymphocytes--immunology<br/>Tumor Suppressor Protein p53--immunology